Please use this identifier to cite or link to this item:
Title: PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
Issue Date: 3-Oct-2018
Citation: BMC Cancer.2018 Oct;(18)1:945
Abstract: The analysis of tumour-infiltrating immune cells within patients' tumour samples in colorectal cancer (CRC) has become an independent predictor of patient survival. The tumour microenvironment and the immune checkpoints, such as PD-L1/PD-1, are relevant to the prognoses and also appear to be relevant for further CRC therapies.
PMID: 30285662
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos
Hospitales > H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC6171318.pdf1.13 MBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.